According to Inotiv's latest financial reports the company's total liabilities are $0.58 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-09-30 | $0.58 B | -2.5% |
2022-09-30 | $0.60 B | 178.29% |
2021-09-30 | $0.21 B | 301.37% |
2020-09-30 | $53.99 M | 72.68% |
2019-09-30 | $31.27 M | 53.4% |
2018-09-30 | $20.38 M | 70.58% |
2017-09-30 | $11.95 M | -12.59% |
2016-09-30 | $13.67 M | 4.46% |
2015-09-30 | $13.08 M | -8.08% |
2014-09-30 | $14.23 M | -11.77% |
2013-09-30 | $16.13 M | -13.23% |
2012-09-30 | $18.59 M | 3.06% |
2011-09-30 | $18.04 M | -5.4% |
2010-09-30 | $19.07 M | -2% |
2009-09-30 | $19.46 M | -13.69% |
2008-09-30 | $22.55 M | -3.96% |
2007-09-30 | $23.48 M | -5.92% |
2006-09-30 | $24.96 M | -11.61% |
2005-09-30 | $28.24 M | 3.16% |
2004-09-30 | $27.37 M | 8.38% |
2003-09-30 | $25.25 M | 73.43% |
2002-09-30 | $14.56 M | 43.54% |
2001-09-30 | $10.14 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $3.14 M | -99.46% | Bahamas |
NRC Health
NRC | $73.48 M | -87.36% | ๐บ๐ธ USA |